Avoid common mistakes on your manuscript.
Correction to: Gastric Cancer https://doi.org/10.1007/s10120-018-0887-x
In the original publication of this article, Table 4 was published incorrectly. The correct Table 4 is given below.
The original article has been corrected. Publisher sincerely apologizes for the error.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yagi, S., Wakatsuki, T., Yamamoto, N. et al. Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer. Gastric Cancer 22, 526 (2019). https://doi.org/10.1007/s10120-018-0900-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10120-018-0900-4